Figure 2.
The Kaplan‐Meier curve of treatment duration of osimertinib stratified according to the type of EGFR‐TKIs used for the treatment before osimertinib. (
) Group A; (
) Group B
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.